[1]
2018. Standardization and optimization of fluorescence in situ hybridization (FISH) for HER-2 assessment in breast cancer: A single center experience. Biomolecules and Biomedicine. 18, 2 (May 2018), 132–140. DOI:https://doi.org/10.17305/bjbms.2018.2519.